Caption Management »

Pliant Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 64k 18.11
2023-09-30 $694k 40k 17.34
2023-06-30 $815k 45k 18.12
2022-06-30 $488k 61k 8.00

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Pliant Therapeutics

T. Rowe Price Associates
First Light Asset Management
Laurion Capital Management
Vanguard Group
Blue Owl Capital Holdings
Redmile Group
Trv Gp Iv
Dr. Jeffrey R. Jay, M.D.
Citadel Advisors
Franklin Resources
Casdin Capital
RA Capital Management
Deutsche Bank Aktiengesellschaft
Bessemer
Candriam Luxembourg S.C.A.

View all funds holding Pliant Therapeutics